Article

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosis

2020-09-23

Abstract excerpt

Immune checkpoint inhibitors (ICIs) have rapidly shifted the landscape of treatments in malignancy with significant improvements in survival paradigm. They have been an attractive armamentarium to the oncologists given the limited immune adverse effects with potential for deeper and durable benefits that haven't been previously noticed with chemotherapy. However, they result in unique toxicities by limiting immune...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3ea8e853-0d0f-5627-8884-f83d7ad7514c
DOI: 10.12688/f1000research.25490.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosisDOI 10.12688/f1000research.25490.1Read

Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma.Semantic proximity Read

Neurologic outcomes in people with multiple sclerosis treated with immune checkpoint inhibitors for oncologic indicationsSemantic proximity Read

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside.Semantic proximity Read

Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management.Semantic proximity Read

Exploring a possible shared pathophysiology in co-occurrence of multiple sclerosis and Hodgkin lymphoma: a case report and review of literatureSemantic proximity Read

Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors.Semantic proximity Read

An update on multiple sclerosis.Semantic proximity Read

Case Report: Fatal myocarditis after combination of immune checkpoint inhibitor and platinum doublet chemotherapySemantic proximity Read

Hypophysitis Induced by Monoclonal Antibodies to Cytotoxic T Lymphocyte Antigen 4: Challenges from a New Cause of a Rare DiseaseSemantic proximity Read

Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan.Semantic proximity Read

Multiple sclerosis: from immunogenetics to immunotherapy.Semantic proximity Read

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).Semantic proximity Read